160 related articles for article (PubMed ID: 23107421)
1. Early life intervention with glucocorticoids has negative effects on motor development and neuropsychological function in 14-17 year-old adolescents.
ter Wolbeek M; de Sonneville LM; de Vries WB; Kavelaars A; Veen S; Kornelisse RF; van Weissenbruch M; Baerts W; Liem KD; van Bel F; Heijnen CJ
Psychoneuroendocrinology; 2013 Jul; 38(7):975-86. PubMed ID: 23107421
[TBL] [Abstract][Full Text] [Related]
2. Neonatal glucocorticoid treatment: long-term effects on the hypothalamus-pituitary-adrenal axis, immune system, and problem behavior in 14-17 year old adolescents.
Ter Wolbeek M; Kavelaars A; de Vries WB; Tersteeg-Kamperman M; Veen S; Kornelisse RF; van Weissenbruch M; Baerts W; Liem KD; van Bel F; Heijnen CJ
Brain Behav Immun; 2015 Mar; 45():128-38. PubMed ID: 25449580
[TBL] [Abstract][Full Text] [Related]
3. Differences in behavioral outcome and motor development at school age after neonatal treatment for chronic lung disease with dexamethasone versus hydrocortisone.
Karemaker R; Heijnen CJ; Veen S; Baerts W; Samsom J; Visser GH; Kavelaars A; van Doornen LJ; van Bel F
Pediatr Res; 2006 Dec; 60(6):745-50. PubMed ID: 17065571
[TBL] [Abstract][Full Text] [Related]
4. Functional outcome at school age of preterm-born children treated with high-dose dexamethasone.
Hitzert MM; Van Braeckel KN; de Bok M; Maathuis CG; Roze E; Bos AF
Early Hum Dev; 2014 May; 90(5):253-8. PubMed ID: 24602475
[TBL] [Abstract][Full Text] [Related]
5. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity.
Yeh TF; Lin YJ; Lin HC; Huang CC; Hsieh WS; Lin CH; Tsai CH
N Engl J Med; 2004 Mar; 350(13):1304-13. PubMed ID: 15044641
[TBL] [Abstract][Full Text] [Related]
6. Time-related changes in steroid use and bronchopulmonary dysplasia in preterm infants.
Yoder BA; Harrison M; Clark RH
Pediatrics; 2009 Aug; 124(2):673-9. PubMed ID: 19620192
[TBL] [Abstract][Full Text] [Related]
7. Effects of neonatal corticosteroid treatment on hippocampal synaptic function.
Huang CC; Lin HR; Liang YC; Hsu KS
Pediatr Res; 2007 Sep; 62(3):267-70. PubMed ID: 17622955
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological and behavioral effects of postnatal dexamethasone in extremely low birth weight preterm children at early school age.
Crotty KC; Ahronovich MD; Baron IS; Baker R; Erickson K; Litman FR
J Perinatol; 2012 Feb; 32(2):139-46. PubMed ID: 21546939
[TBL] [Abstract][Full Text] [Related]
9. Hydrocortisone vs. dexamethasone treatment for bronchopulmonary dysplasia and their effects on general movements in preterm infants.
Hitzert MM; Benders MJ; Roescher AM; van Bel F; de Vries LS; Bos AF
Pediatr Res; 2012 Jan; 71(1):100-6. PubMed ID: 22289857
[TBL] [Abstract][Full Text] [Related]
10. Neonatal hydrocortisone treatment: neurodevelopmental outcome and MRI at school age in preterm-born children.
Rademaker KJ; Uiterwaal CS; Groenendaal F; Venema MM; van Bel F; Beek FJ; van Haastert IC; Grobbee DE; de Vries LS
J Pediatr; 2007 Apr; 150(4):351-7. PubMed ID: 17382109
[TBL] [Abstract][Full Text] [Related]
11. Policy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
Watterberg KL;
Pediatrics; 2010 Oct; 126(4):800-8. PubMed ID: 20819899
[TBL] [Abstract][Full Text] [Related]
12. Functioning of 7-year-old children born at 32 to 35 weeks' gestational age.
Cserjesi R; Van Braeckel KN; Butcher PR; Kerstjens JM; Reijneveld SA; Bouma A; Geuze RH; Bos AF
Pediatrics; 2012 Oct; 130(4):e838-46. PubMed ID: 22945414
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin 2 concentrations in infants developing bronchopulmonary dysplasia: attenuation by dexamethasone.
Aghai ZH; Faqiri S; Saslow JG; Nakhla T; Farhath S; Kumar A; Eydelman R; Strande L; Stahl G; Leone P; Bhandari V
J Perinatol; 2008 Feb; 28(2):149-55. PubMed ID: 18033304
[TBL] [Abstract][Full Text] [Related]
14. Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone?
van der Heide-Jalving M; Kamphuis PJ; van der Laan MJ; Bakker JM; Wiegant VM; Heijnen CJ; Veen S; van Bel F
Acta Paediatr; 2003 Jul; 92(7):827-35. PubMed ID: 12892163
[TBL] [Abstract][Full Text] [Related]
15. Transient increase in intraocular pressure during a dose-tapering regime of systemic dexamethasone in preterm infants.
Ng PC; Lee CH; Tam BS; Wong SP; Lam HS; Kwok AK; Fok TF
Ophthalmology; 2008 May; 115(5):e7-14. PubMed ID: 18321580
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone induces neurodegeneration but also up-regulates vascular endothelial growth factor A in neonatal rat brains.
Feng Y; Rhodes PG; Liu H; Bhatt AJ
Neuroscience; 2009 Jan; 158(2):823-32. PubMed ID: 19007863
[TBL] [Abstract][Full Text] [Related]
17. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero.
Brucato A; Astori MG; Cimaz R; Villa P; Li Destri M; Chimini L; Vaccari R; Muscarà M; Motta M; Tincani A; Neri F; Martinelli S
Ann Rheum Dis; 2006 Nov; 65(11):1422-6. PubMed ID: 16504990
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy.
Powell K; Kerkering KW; Barker G; Rozycki HJ
J Matern Fetal Neonatal Med; 2006 Jan; 19(1):43-8. PubMed ID: 16492591
[TBL] [Abstract][Full Text] [Related]
19. Trial of early neonatal hydrocortisone: two-year follow-up.
Peltoniemi OM; Lano A; Puosi R; Yliherva A; Bonsante F; Kari MA; Hallman M;
Neonatology; 2009; 95(3):240-7. PubMed ID: 18931525
[TBL] [Abstract][Full Text] [Related]
20. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease.
Gross SJ; Anbar RD; Mettelman BB
Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
